Delivery Order SPE2DB24D2010-SPE2DB25FAALJ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,170.98 to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5mL) on June 16, 2025, with completion scheduled for June 17, 2025. This non-competed delivery order represents a firm fixed price transaction processed under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5mL) valued at $22,721.30 under a firm fixed-price contract. The award was made on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-set-aside delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal conjugate vaccine used for immunization programs within military and federal...
- The Defense Logistics Agency awarded a delivery order valued at $35,155.89 to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of PREVNAR 20 syringe units (0.5ML). This contract represents a firm fixed price delivery order with no set-aside designation, indicating competitive award through open market solicitation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order is scheduled for...
- The Defense Logistics Agency awarded a delivery order valued at $2,052.93 to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5mL) on June 2, 2025, with completion scheduled for June 3, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award to this major pharmaceutical distributor. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $5,281.88 to supply PREVNAR 20 syringes (0.5ML) under a firm fixed price contract. The order was competitively awarded with no set-aside designation and is scheduled for completion by September 11, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $12,261.63 firm fixed price delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5mL) on August 12, 2025, with an ultimate completion date of August 13, 2025. This is a non-set-aside contract, competitively awarded to the pharmaceutical distributor's Corporate Office division located in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal conjugate vaccine used to prevent pneumococcal disease in eligible populations, representing...
- The Defense Logistics Agency awarded a delivery order valued at $47,295.80 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 syringes (0.5mL) with a completion date of September 10, 2025. This competitively awarded, firm fixed-price contract represents a single delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office location in the same city....
- The Defense Logistics Agency awarded a delivery order valued at $8,453.56 to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5ML) on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal conjugate vaccine used for immunization against pneumococcal...
- The Defense Logistics Agency awarded a $91,040.52 delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 syringe 0.5ML on July 18, 2025, with an ultimate completion date of July 21, 2025. This is a firm fixed price, non-set-aside contract with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $24,506.55 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 syringes (0.5mL) on July 24, 2025, with an ultimate completion date of July 25, 2025. This delivery order represents a competitive, firm fixed-price award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal conjugate vaccine used for immunization against pneumococcal disease,...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB25FAALJDelivery Order
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5mL) valued at $6,760.81 under a firm fixed-price arrangement. This non-set-aside delivery order was awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal conjugate vaccine used to prevent pneumococcal disease and represents part of the company's broader pharmaceutical and medical supply distribution portfolio to federal healthcare systems. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor, AmerisourceBergen leverages this comprehensive global contract vehicle to supply medications, vaccines, syringes, and specialized medical commodities to support military healthcare programs and other federal government health systems worldwide. The company's consistent receipt of competitively awarded delivery orders demonstrates its established capability to meet federal medical procurement requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 7/22/25 |